Home Effectiveness of interventions to improve test appropriateness
Article Publicly Available

Effectiveness of interventions to improve test appropriateness

  • Michael P. Cornes EMAIL logo
Published/Copyright: January 20, 2022

Laboratory testing is critical to the provision of care to the population served by a healthcare institution. It has been reported that laboratory tests are involved in around 70% of clinical decisions regarding patient care and are involved in 95% of patient pathways. Given the critical role played it is therefore essential that the right tests are performed at the right time. It is therefore important to define what is an appropriate test. An appropriate test should contribute to a patient’s diagnosis in either a confirmatory or eliminatory way, help guide patient care, add value in addition to other tests requested, not be an unnecessary repeat and be in line with current guidelines [1]. Inappropriate tests are defined as tests that are not indicated, are indicated but not requested or tests that are appropriately requested but are then not acted on in an appropriate manner [1]. As these definitions show appropriateness refers to not just ensuring that inappropriate testing is avoided, but also to ensure that appropriate tests are not missed. It has been reported that the level of inappropriate requests could be anywhere between 5 and 95% but additionally it has also been reported that the rate of missed appropriate tests is around 50% [1].

The consequences of inappropriate testing are significant for both the patient and the hospital. By definition 5% of normal patient results will lie outside of the reference range and in this situation will need to be followed up. If there was no indication for the initial test this can lead to unnecessary follow ups, phlebotomy sessions and repeated tests and perhaps most significantly increased stress for the patient [2, 3]. On the flip side, a failure to request a test that would have been appropriate or a failure to act on the result can lead to missed diagnosis and therefore patient harm. In both of these scenarios there is the potential for litigation against the hospital [4].

There are many possible contributing factors that cause inappropriate requesting. The first of these is due to the progression within laboratory medicine over the last few decades meaning there is now a significantly bigger repertoire of tests available at ever decreasing speed and due to electronic requesting these are all now much easier to request. The second significant factor is defensive medicine due to fear of litigation with over 90% of clinicians stating they have requested tests solely because of a threat of liability. This is backed up by the in the US over 50% of malpractice claims related to misdiagnosis were due to a failure to order the appropriate test [4]. A third potential factor is due to the decreasing education in laboratory medicine as part of medical training leading to a lack of understanding of the diagnostic value of a test. A final but very significant factor, especially in the modern world with ready access to online information and misinformation is patient demand, which can in turn link back into the fear of litigation [1, 2].

Given that we are aware that there are significant levels of inappropriate testing what can we as laboratory professionals due to improve the situation. The article by Lillo et al. in a previous issue of CCLM looked at the interventions in primary care and found that most took the approach of education either alone or coupled to feedback reports, whereas the use of electronic ordering mechanisms as usually used in the hospital setting was not considered [5]. In their follow up article in this issue of the Journal they perform a randomised controlled study of six different approaches to improve the appropriateness of Vitamin D requesting in primary care [6]. The six different interventions were based on different combinations of issuing guidelines, providing feedback reports to the surgeries, using non-interruptive alerts (the user just needs to click ok to proceed) and interruptive alerts (user needs to enter information to proceed). What they found was that in all groups there was a reduction, over and above the reduction seen in the control group but only in the group where there was an alert did this become significant. It therefore seems clear that issuing guidelines alone has very little impact, a finding that is in line with other studies [6]. It is unclear what the reasons for this might be but one reason could be that it is very difficult to change the way people have worked for the rest of their careers. It may also be a lack of awareness of changes to guidance or in some cases a disagreement with them and therefore a following of local guidelines. There is always a tendency to revert back without repeated reminders [2].

The best way to prevent this reversion back to previous practice is to use clinicians electronic requesting systems. The alternative to this is repeated education but this is hard to maintain, doesn’t capture all users and lacks the real time feedback element you can get by using the order communication system. There are three ways in which to use alerts to help optimise requesting. Two of these are discussed in the paper and involve the use of pop up boxes. As discussed above these can either just be a pop up alert to remind the clinicians or the recommendation which they can then choose to follow or take a different course, or a pop up that requires some feedback in order to progress with the request. The other harder line approach is to use a pop up to state that the test will not be processed unless the laboratory is phoned to override automated rules. This works well for tests that are repeated within an inappropriate timeframe. The disadvantage of this is that it does not prevent the sample being taken and therefore a patient may have been bled unnecessarily and potentially get no results. The ideal would be to prevent the sample being taken in the first place. However, although pop up alerts are the best mechanism there needs to be a careful balance of the number of these in use to avoid alert fatigue. This occurs when there are too many alerts which then no longer get read and are users do whatever it takes to get past the alert and get the test requested [7].

What was interesting in the study was that although there was the desired reduction in Vitamin D requests a second aim of the study, which was to check that the reduction was due to a reduction in inappropriate requests wasn’t seen, or didn’t present in the expected way. The expectation was that there would be a relative increase in the number of low Vitamin D levels but this was not seen [6]. Possible explanations for this could be that the guidelines are not appropriate or that low vitamin D levels are an effect of a clinical condition meaning a patient is less able to access sunlight meaning that the low level is an effect rather than a cause and therefore not currently part of the diagnosis [6]. Another possible reason, as highlighted in the article is that demand optimisation is synonymous with reducing test requesting and therefor the clinicians may have viewed this study as a drive to purely reduce test volume and therefore reduced test requesting in a more randomised way. It would be interesting to look at the clinical impact of similar interventions on appropriateness of requesting for other analyses.

In order to ensure that any optimisation strategies are successful it is important to follow several key principles. Most critical of these is to engage with the clinicians and users of the service and get their buy in following a discussion of why it is important for the patient. It is also very important to regularly review the strategies to make sure they are still appropriate with current guidance. A good tool to help with this is when an interruptive alert is used. The data collected from that interruptive alert can be used to review how the strategy is working and allow it to evolve as new information is published. With all approaches it is critical to ensure that they are seen as a tool to ensure patients receive the correct test during initial consultations as this is the best way to ensure that errors are reduced and patients receive the best standard of care which must be at the core of all we do [7]. A good way to ensure that the correct tests are requested first time is to use care sets. These are request profiles based on a clinical condition e.g. abdominal pain or chest pain. Each care set is agreed with clinical teams and would contain only the tests relevant to investigate the clinical condition. Additional tests can be added to the care sets to reflect the clinical questions being asked [8].


Corresponding author: Dr. Michael P. Cornes, Worcestershire Acute Hospitals NHS Trust, Worcester Royal Hospital, Worcester WR5 1DD, Worcester, UK, E-mail:

  1. Research funding: None declared.

  2. Author contributions: Single author contribution.

  3. Competing interests: Author states no conflict of interest.

References

1. Cadamuro, J, Ibarz, M, Cornes, M, Nybo, M, Haschke-Becher, E, von Meyer, A, et al.. Managing inappropriate utilization of laboratory resources. Diagnosis (Berl) 2019;6:5–13. https://doi.org/10.1515/dx-2018-0029.Search in Google Scholar PubMed

2. Freedman, DB. Towards better test utilization – strategies to improve physician ordering and their impact on patient outcomes. EJIFCC 2015;26:15–30.Search in Google Scholar

3. Whiting, D, Croker, R, Watson, J, Brogan, A, Walker, AJ, Lewis, T. Optimising laboratory monitoring of chronic conditions in primary care: a quality improvement framework. BMJ Open Qual 2019;8:e000349. https://doi.org/10.1136/bmjoq-2018-000349.Search in Google Scholar PubMed PubMed Central

4. Studdert, DM, Mello, MM, Sage, WM, DesRoches, CM, Peugh, J, Zapert, K, et al.. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. J Am Med Assoc 2005;293:2609–17. https://doi.org/10.1001/jama.293.21.2609.Search in Google Scholar PubMed

5. Lillo, S, Larsen, TR, Pennerup, L, Antonsen, S. The impact of interventions applied in primary care to optimize the use of laboratory tests: a systematic review. Clin Chem Lab Med 2021;59:1336–52. https://doi.org/10.1515/cclm-2020-1734.Search in Google Scholar PubMed

6. Lillo, S, Larsen, TR, Pennerup, L, Kyvik, K, Søndergaard, J, Antonsen, S. A randomized controlled study of biochemical tests in primary care: interventions can reduce the number of tests but usage does not become more appropriate. Clin Chem Lab Med 2022;60:343–50. https://doi.org/10.1515/cclm-2021-1138.Search in Google Scholar PubMed

7. Zhi, M, Ding, EL, Theisen-Toupal, J, Whelan, J, Arnaout, R. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One 2013;8:e78962. https://doi.org/10.1371/journal.pone.0078962.Search in Google Scholar PubMed PubMed Central

8. https://future.nhs.uk/system/login?nextURL=%2Fconnect%2Eti%2FGIRFTNational%2Fview%3FobjectId%3D112161637.Search in Google Scholar

Published Online: 2022-01-20
Published in Print: 2022-02-23

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Obituary
  3. Dr Per Hyltoft Petersen: an appreciation
  4. Editorials
  5. Extrapolated normative GFR data for living kidney donation
  6. Effectiveness of interventions to improve test appropriateness
  7. Reviews
  8. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors
  9. S100B in cardiac surgery brain monitoring: friend or foe?
  10. Mini Review
  11. Blood lactate concentration in COVID-19: a systematic literature review
  12. Opinion Paper
  13. Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants
  14. General Clinical Chemistry and Laboratory Medicine
  15. A randomized controlled study of biochemical tests in primary care: interventions can reduce the number of tests but usage does not become more appropriate
  16. A national surveillance program for evaluating new reagent lots in medical laboratories
  17. External quality assessment providers’ services appear to more impact the immunohaematology performance of laboratories than national regulatory and economic conditions
  18. International collaborative study to evaluate and calibrate two recombinant L chain Ferritin preparations for use as a WHO International Standard
  19. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer
  20. Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patients
  21. Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations
  22. Reference Values and Biological Variations
  23. Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years
  24. Indirectly determined hematology reference intervals for pediatric patients in Berlin and Brandenburg
  25. Hematology and Coagulation
  26. Monocyte distribution width (MDW): a useful biomarker to improve sepsis management in Emergency Department
  27. Diabetes
  28. A step towards optimal efficiency of HbA1c measurement as a first-line laboratory test: the TOP-HOLE (Towards OPtimal glycoHemOgLobin tEsting) project
  29. Labile glycated hemoglobin: an underestimated laboratory marker of short term glycemia
  30. Infectious Diseases
  31. Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays
  32. Letters to the Editors
  33. Molecular detection of SARS-CoV-2 eta VOI in Northern Italy: a case report
  34. Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?
  35. Measurement in different sample types may aid in detecting interferences and macrocomplexes affecting cardiac troponin measurements
  36. Which method to detect macrotroponin?
  37. Marked geographical variation in the prevalence of macroprolactinemia
  38. Pancreatic lipase assays: time for a change towards immunoassays?
  39. Analytical evaluation of the performances of a new procalcitonin immunoassay
  40. Necessity of harmonization of tissue transglutaminase IgA assays to align clinical decision making in coeliac disease
  41. A fortuitous but characteristic blood smear observation allowing a late diagnosis of MPS-VII
  42. Prognostic significance of blood-based multi-cancer detection in plasma cell-free DNA
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0033/html
Scroll to top button